The goal of the conference is to bring together the scientific data and expertise (focusing on vaccine and antiviral developments) and connecting the stakeholders involved in RSV research e.g. scientists, physicians, pharmaceutical companies, regulators and representatives from FDA, PATH, WHO, EMA, NIH and BMGF. Researchers and physicians from all over the world are invited to join the discussions and share their knowledge. Specifically, scientists and physicians from low- and middle income countries (LMICs) and young researchers are being encouraged and supported to participate in this meeting. We endeavour to stimulate discussions regarding the opportunities for future international collaboration and achievements in our field.